Avanos Medical reported quarterly EPS of $0.22, missing the Zacks consensus estimate of $0.23 and down from $0.26 a year ago. The 1-cent miss is modest, but the year-over-year decline signals some pressure on profitability. The headline is likely to weigh slightly on the shares, though the impact should be limited absent additional revenue or guidance details.
Avanos Medical reported quarterly EPS of $0.22, missing the Zacks consensus estimate of $0.23 and down from $0.26 a year ago. The 1-cent miss is modest, but the year-over-year decline signals some pressure on profitability. The headline is likely to weigh slightly on the shares, though the impact should be limited absent additional revenue or guidance details.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.24
Ticker Sentiment
